Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares fell 2.6% during trading on Thursday. The company traded as low as GBX 1.12 and last traded at GBX 1.12. Approximately 347,880 shares changed hands during mid-day trading, a decline of 80% from the average session volume of 1,771,369 shares. The stock had previously closed at GBX 1.15.
Cizzle Biotechnology Price Performance
The company’s 50-day simple moving average is GBX 1.39 and its 200-day simple moving average is GBX 1.96. The stock has a market capitalization of £5.62 million, a price-to-earnings ratio of -7.31 and a beta of 0.02.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last issued its quarterly earnings data on Wednesday, September 30th. The company reported GBX (0.08) earnings per share (EPS) for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Cizzle Biotechnology
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
